1-2 of 2
IIseung Choi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I and Pharmacokinetic (PK) Study of Everolimus (RAD001) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL).

Michinori Ogura, MD, PhD, Toshiki Uchida, MD, PhD, Dai Maruyama, MD, PhD, Naokuni Uike, MD, PhD, IIseung Choi, MD, PhD, Kenichi Ishizawa, MD, PhD, Kuniaki Itoh, MD, PhD, Kiyoshi Ando, MD, PhD, Masafumi Taniwaki, MD, PhD, Naomi Shimada, Ken Kobayashi, MD, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1712.
https://doi.org/10.1182/blood.V114.22.1712.1712
Published: 2009
Journal Articles

Bendamustine Is Highly Effective for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle Cell Lymphoma (MCL): Final Results of a Japanese Multicenter Phase II Study.

Michinori Ogura, MD, PhD, Toshiki Uchida, MD, PhD, Kiyoshi Ando, MD, PhD, Ken Ohmachi, MD, PhD, Kuniaki Itoh, MD, PhD, Nobuko Kubota, MD, PhD, Kenichi Ishizawa, MD, PhD, Joji Yamamoto, MD, PhD, Takashi Watanabe, MD, PhD, Naokuni Uike, MD, PhD, IIseung Choi, MD, PhD, Yasuhito Terui, MD, PhD, Kensuke Usuki, MD, PhD, Hirokazu Nagai, MD, PhD, Nobuhiko Uoshima, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3694.
https://doi.org/10.1182/blood.V114.22.3694.3694
Published: 2009